New Vernon Capital Holdings Ii LLC Catalyst Pharmaceuticals, Inc. Transaction History
New Vernon Capital Holdings Ii LLC
- $4.38 Billion
- Q1 2025
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 327,860 shares of CPRX stock, worth $7.18 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
327,860
Previous 5,822
5531.4%
Holding current value
$7.18 Million
Previous $121,000
11073.55%
% of portfolio
0.31%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding CPRX
# of Institutions
390Shares Held
99.9MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$409 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$186 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$121 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$74.9 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$68.6 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.25B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...